12 Health Care Stocks Moving In Thursday's Pre-Market Session

Loading...
Loading...

Gainers

  • Panbela Therapeutics PBLA shares rose 62.0% to $1.29 during Thursday's pre-market session. The company's market cap stands at $3.8 million.
  • Cellectis CLLS stock increased by 17.04% to $3.09. The market value of their outstanding shares is at $171.7 million.
  • CareDx CDNA shares moved upwards by 14.78% to $6.21. The market value of their outstanding shares is at $336.3 million.
  • Avenue Therapeutics ATXI stock rose 12.6% to $0.26. The company's market cap stands at $2.3 million.
  • Genprex GNPX shares moved upwards by 12.54% to $0.25. The company's market cap stands at $14.9 million.
  • Akanda AKAN stock rose 12.41% to $0.48. The market value of their outstanding shares is at $1.8 million.

Losers

  • Outlook Therapeutics OTLK stock declined by 63.1% to $0.23 during Thursday's pre-market session. The market value of their outstanding shares is at $60.7 million.
  • DarioHealth DRIO stock fell 25.86% to $0.75. The company's market cap stands at $20.3 million. As per the news, the Q3 earnings report came out today.
  • Acurx Pharmaceuticals ACXP stock fell 24.46% to $3.83. The market value of their outstanding shares is at $49.8 million.
  • Moderna MRNA shares fell 13.13% to $66.2. The company's market cap stands at $25.1 billion. The company's, Q3 earnings came out today.
  • Sonendo SONX shares fell 12.42% to $0.23. The market value of their outstanding shares is at $12.2 million.
  • Envista Holdings NVST shares decreased by 11.92% to $20.25. The company's market cap stands at $3.3 billion. As per the news, the Q3 earnings report came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...